Skip to main content
. Author manuscript; available in PMC: 2017 May 1.
Published in final edited form as: Int J Tuberc Lung Dis. 2016 May;20(5):631–637. doi: 10.5588/ijtld.15.0788

Table 3.

Performance parameters of MTBDRplus v2 by Study Site

Resistance Smear Status Isolates Sensitivity % Specificity %
India RIF 438 98.0 (95.8, 99.1) 98.8 (92.5, 99.9)

 AFB+ 422 98.0 (95.7, 99.1) 98.7 (91.9, 99.9)
 AFB− 16 100.0 (62.9, 100.0) 100.0 (56.1, 100.0)

INH 433 97.3 (94.9, 98.6) 100.0 (93.3, 100.0)

 AFB+ 418 97.5 (95.1, 98.9) 100.0 (92.9, 100.0)
 AFB− 15 90.9 (57.1, 99.5) 100.0 (39.6, 100.0)

MDR-TB 426 96.2 (93.4, 97.9) 98.8 (92.5, 99.9)

 AFB+ 411 96.4 (93.6, 98.0) 98.7 (92.0, 99.9)
 AFB− 15 88.9 (50.7, 99.4) 100.0 (51.7, 100.0)

Moldova RIF 204 97.0 (90.9, 99.2) 98.1 (92.5, 99.7)

 AFB+ 166 98.7 (92.0, 99.9) 97.8 (91.4, 99.6)
 AFB− 38 91.7 (71.5, 98.5) 100.0 (73.2, 100.0)

INH 193 92.7 (85.7, 96.6) 100.0 (94.5, 100.0)

 AFB+ 161 94.4 (86.8, 97.9) 100.0 (93.7, 100.0)
 AFB− 32 85.7 (62.6, 96.2) 100.0 (67.9, 100.0)

MDR-TB 190 94.5 (87.1, 98.0) 99.0 (93.7, 99.9)

 AFB+ 158 98.6 (91.5, 99.9) 98.8 (92.8, 99.9)
 AFB− 32 78.9 (53.9, 93.0) 100.0 (71.7, 100.0)

South Africa RIF 167 72.2 (49.6, 88.4) 97.2 (92.6, 99.1)

 AFB+ 124 75.0 (50.6, 90.4) 99.0 (94.0, 99.9)
 AFB− 43 50.0 (2.7, 97.3) 92.7 (79.0, 98.1)

INH 164 61.8 (43.6, 77.3) 99.2 (95.2, 100.0)

 AFB+ 120 64.3 (44.1, 80.7) 100.0 (95.0, 100.0)
 AFB− 44 50.0 (13.9, 86.1) 97.4 (84.6, 99.9)

MDR-TB 159 77.8 (51.9, 92.6) 99.3 (95.5, 100.0)

 AFB+ 117 76.5 (49.8, 92.2) 100.0 (95.4, 100.0)
 AFB− 42 100.0 (5.5 100.0) 97.6 (85.6, 99.9)